Cannae Holdings director granted 4,616 restricted CNNE shares

Cannae Holdings director reports restricted stock grant A director of Cannae Holdings, Inc. reported receiving 4,616 shares of common stock as a restricted stock grant on December 15, 2025.

Rhea-AI Filing Summary

Cannae Holdings director reports restricted stock grant

A director of Cannae Holdings, Inc. reported receiving 4,616 shares of common stock as a restricted stock grant on December 15, 2025. The award was recorded at a price of $0 per share, reflecting an equity compensation grant rather than an open-market purchase. These restricted shares are scheduled to vest in three equal annual installments beginning December 15, 2026.

After this grant, the director beneficially owns 5,122.9754 shares of Cannae Holdings common stock directly, plus 900 shares held indirectly through the K6 Investments Defined Benefit Plan.

Insider Trade Summary

Grant/Award: 4,616 shares

Grant/Award 2 txns

Insider Aboelnaga Mona

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,616	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 5,122.9754 shares (Direct); Common Stock — 900 shares (Indirect, K6 Investments. Defined Benefit Plan)

Footnotes (1)

1. F1. Grant of restricted stock vesting in three equal annual installments beginning December 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cannae Holdings (CNNE) disclose in this Form 4?

A director of Cannae Holdings, Inc. reported receiving a grant of 4,616 shares of restricted common stock as an equity compensation award on December 15, 2025.

How many Cannae Holdings (CNNE) shares were granted and at what price?

The director was granted 4,616 shares of Cannae Holdings common stock, recorded at a price of $0 per share as a restricted stock award.

When do the restricted Cannae Holdings (CNNE) shares begin vesting?

The 4,616 restricted shares vest in three equal annual installments beginning on December 15, 2026, according to the explanation of responses.

How many Cannae Holdings (CNNE) shares does the director now beneficially own?

Following the reported transaction, the director beneficially owns 5,122.9754 shares of Cannae Holdings common stock directly, plus 900 shares held indirectly.

What indirect ownership in Cannae Holdings (CNNE) is reported on this Form 4?

The Form 4 states that 900 shares of Cannae Holdings common stock are held indirectly through the K6 Investments Defined Benefit Plan.

What is the reporting persons relationship to Cannae Holdings (CNNE)?

The reporting person is identified as a Director of Cannae Holdings, Inc., and the form is filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/17/2025 - 05:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aboelnaga Mona

(Last) (First) (Middle)

1701 VILLAGE CENTER CIRCLE

(Street)

LAS VEGAS NV 89134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cannae Holdings, Inc. [ CNNE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2025		A		4,616(1)	A	$0	5,122.9754	D
Common Stock								900	I	K6 Investments. Defined Benefit Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock vesting in three equal annual installments beginning December 15, 2026.

	/s/ Carol Nairn, as attorney-in-fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.